8. June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunology Today 1990;11:211-16.
9. Woerly G, Roger N, Loiseau S, Dombrowicz D, Capron A. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complex. J Exp Med 1999;190:487-95.
10. Martínez A, Montoya CJ. Transducción de señales generadas a partir del receptor antigénico de los linfocitos T. Iatreia 1999;12:168-77.
11. Linsley PS, Ledbetter JA. The role of the CD28 receptor during Tcell responses to antigen. Annu Rev Immunol 1993;11:191-212.
12. Schwartz RH. Costimulation of Lymphocytes: The Role of CD28, CTLA-4, and B7/BB1 in Interleukin-2 Production and Immunotherapy. Cell 1992;71:1065-68.
13. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 System of TCell Costimulation. Annu Rev Immunol 1996;14:233-58.
14. Fernandez-Ruiz E, Somoza C, Sanchez-Madrid F, Lanier LL. CD28/CTLA-4 ligands: the gene encoding CD86 (B70/B7.2) maps to the same region as CD80 (B7/B7.1) gene in human chromosome 3q13-q23. Eur J Immunol 1995;25:1453-56.
15. Jeannin P, Herbault N, Delneste Y, et al. Human Effector Memory T Cells Express CD86: A Functional Role in Naive T Cell Priming. J Immunol 1999;162:2044-48
16. Fujihara M, Takahashi TA, Azuma M, et al. Decreased Inducible Expresion of CD80 and CD86 in Human Monocytes After Ultraviolet- B Irradiation: Its Involvement in Inactivation of Allogenecity. Blood 1996;87:2386-93.
17. Nuriya S, Yagita H, Okumura K, Azuma M. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity. Int Immunol 1996;8:917-26.
18. Lanier LL, O´Fallon S, Somoza C, et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995;154:97-105.
19. Jaffar ZH, Stanciu L, Pandit A, Lordan J, Holgate ST, Roberts K. Essential role for both CD80 and CD86 costimulation, but not CD40 interactions, in allergen-induced the cytokine production from asthmatic bronchial tissue: role for alphabeta, but not gammadelta, T cells. J Immunol 1999;163:6283-91.
20. Ueda Y, Levine BL, Huang ML, et al. Both CD28 ligans CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3 kinase and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int Immunol 1995;7:957-66.
21. Slavik JM, Hutchcroft JE, Bierer BE. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28. J Bio Chem 1999;274:3116-24.
22. Nunes JA, Battifora M, Woodget JR, Truneh A, Olive D, Cantrell DA. A comparison of B7-1 and B7-2 regulation of the MAP kinases: ERK 2 and Jun kinases. Mol Immunol 1996;33:63-70.
23. Penninger JM, Timms E, Shahinian A, et al. Aloreactive gamma delta thymocytes utilize distinct costimulatory signals from peripheral T cells. J Immunol 1995;155:3847-55).
24. Liu Y: Is CTLA-4 a negative regulador for T cell activation? Inmunol Today, 18:569-572, 1997.
25. Walunas T, Lenschow D, Bakker C, Linsley P, Freeman G, Greem J. CTLA-4 can funtion as a nigative regulator of T cell activation. Inmunity; 1:405-413, 1994.
26. Waterhouse P, Penninger J, Timms E, Wakeham A, Shahinian A, Lee K. lymphoproliferative disorders with early lethality in mice defecient in CTLA-4. Science; 270:985-988, 1995.
27. Tivol E, Borriello F, Schweitzer A, Sharpe H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Inmunity; 3:541-547, 1995.
28. Chambers C, Sullivan T, Allison J. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-depent activation of CD4 T cell. Inmuntity;7:885-895, 1997.
29. Wagner D, Hagman J, Linsley P, Hodsdon W, Freed J, Newell M. rescue of thymocitrs from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costmulatory interactions with B7-1/B7-2. J. Exp. Med;184:1631-1638, 1996.
30. Vanderborre K, Delabie J, Boogaerts M, De vos R, Lorre K. Human CTLA-4 is expressed in situ on T lymphocytes in germinal centers, in cutaneous graft-versus-host disease and in Hodgkin`s disease. Am. J. Pathol.; 152:963-973, 1995
31. Waterhouse P, Bachmann M, Pennigers J, Ohashi P. Normal thymic selection, noemal viability and decreased lymphoproliferation in T cell receptor tansgenic CTLA-4-deficient mice. Eur J Immunol; 27:1887-1892, 1997.
32. Chambers C, Caso D, Thruong T, Allison J. Thymocyte development is normal in CTLA-4-deficient mice.Proc Natl Acad Sci;94:9296-9301, 1997
33. Romagnani S. Th1 and Th2 in human diseases. Clin Immumol Immunopathol. 80:225-235, 1996.
34. Freeman G, Lombard B, Gimmi CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. J Immunol;149:3795-3801, 1992.
35. Alegre M, Schiels H Thomsomp C. Expresion and fuction of CTLA-4 in Th1 and Th2 cells; J immunol;3347-3356,1998.
36. Fallarino F, Fields P, Gajewski T. B7-1 engagement of cytotoxic T lymphpcyte antigen 4 inhibits T cell activation in the absence of CD28. J Exp Med.188:205-210, 1998.
37. Scheipers P, Reiser H. Fas-independent death of activated CD4 T lymphpcytes induced by CTLA-4 crosslinking. Proc Natl Acad Sci;95:10083-10088, 1998.
38. Van P, Abbas A. Homeostasis and self-tolerance in the immune system: Turning lymphpcytes off;280:243-248, 1998
39. Greenwald R, Bousssiotis V, Lorsbach R, Abbas A, Sharpe A. CTLA-4 regulates indution of anergy in vivo. Immunity 14:145-55, 2001.
40. Taams L, Wauben M. Anergic T cell as active regulators of the immune response. Hum immunol. 61: 633-39, 2000
41. Malvey E, Jenkins M, Muellers D. Peripheral immune tolerance blocks clonal expansion but fails to prevent the ddifferentiation of Th1 cell. J Immunol. 161:2168-77, 1998
42. Mollereau B Deckert M, Deas O, Rieux F, Hirsch F, Bernard A. CD2-induced apoptosis in activated human peripheral T cell: A Fas-independent pathway that requires early protein tyrosine phosphorylation. J Immunol. 156:3184-3190, 1996.
43. Park C, Yashiro Y, Tai X,Toyooka K, Hamaoka T. Differential involvement of a Fas-CPP32-like protease pathway in apoptosis of TCR/CD9-costimulated, activated, naïve T cells. J Immunol; 160:5790-5796, 1998.
44. Van P, Biuckians A, Abbas A. Functional roles of Fas and Bcl-2-regulated apoptosis of T Lymphocytes. J immunol.160: 2065-2071, 1998.
45. Schuart R. Models of T cells anergy: is there a commun moleculae mechanism?. J Exp Med.184:1-8, 1996.
46. Bradshaw J, Lu P, Leytza G, Rodgers J, Schieven G, Bennett K. Interaction of the cytoplasmatic tail of CTLA-4 (CD152) with a clahrin-associated protein is negatively regulated by tyrosine phosphorylation. Biochenistry; 36:15975-15982, 1997.
47. Zhang Y, Allison J. Interaction of CTLA-4 with AP50, a clathrincoated pit adaptor protein. Proc Natl Acad Sci USA;94:8273-9278, 1997.
48. Sheneiders H, Preasad K, Shoelson S, Rudd C. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J Exp Med; 181:351-355, 1995
49. Marengered L, Waterhause P, Duncan G, Mittrucker H, Feng G, Mak T. Tegulation of T cells receptor signalin by tyrosine phosphatase SYP association with CTLA-4. Science. 272:1170-1173, 1996.
50. Burshtyn D, Scharenberg A, Wagtmas N, Rajagopalan S, Berrada K, Yi T. Recruiment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity. 4:77-85,1996
51. D` Ambrosio D, Hippen K, Minskoff S, Mellmam I, Pani G. recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1. Science.268:293-297, 1995.
52. Boussitios V, Freemam G, Berezovskaya A, Barder L, Nadler L. maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activited Rap 1. Science;278: 124-128, 1997.
53. Sundsedt A, Sigvardsson M, Leanderson T, Hedlum D, Kalland T. In vivo anergized CD4 T cell express perturbed AP-1 and MF-κβ transcription factors. Proc Natl Acad Sci USA;93:979-984, 1996
54. Blair P, Riley J, Levine V, Lee K, Craighead N, Francomano T. CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits IL-2 secretion but allows Bclx induction. J immunol; 160:12-15, 1998
55. Lai J, Tan T. CD28 signaling causes a sustained down.regulation of IκB which can be prevented by the immunosuppressant eapamycin. J Biol Chem;269:30077-30080, 1994
56. Harhaj E, Maggirwars S, Good L, Sun S. CD28 mediates a potent costimulatoey signal for rapid degradation of Iκ Bβ which associated with accelerated activation of vatious NFκβ/Rel heterodimers. Mol Cell Biol. 16:6736-6743, 1996
57. Ravi R, Bedi A, Fuchs E. CD95 (Fas)-enduced caspase-mediated proteolysis of NFκβ. Cancer Res;58:882-886, 1998
58. Pioli C, Goso C, Francesconi A, Frasca D, Doria G. CTLA-4 negatively regulates cytokine production by NFκβ modulation. Keystone symposia, Keystone, CO, p 82, 1998
59. Hakem R, Hakem A, Duncan G, Henderson J, Woo M, Soengans M. Differential requirement for caspase 9 in apoptotic pathxays in vivo. Cell;94:339-352, 1998
60. Varfoloment E, Schuchmam M, Luria V, Chiannkulchai N, Mett I. Targeted disruption of the mouse caspase 8 gene ablates cell death induction for TNF receptor, Fas/Apo1, and DE3 and is lethal prenatally. Immunity;9:267-276, 1998
61. Li w, Whaley C, Mondino A, Mueller D. Blocked signal transduction to the ERK and JNK protein kinase in anergic CD4 T cells. Science; 271:1272-1276, 1996.
62. Ochi A, Kaga S, Berg K. Posstive and negative segnalling of T cell activation. Keystone symposia, Keystone, CO p 59, 1998